News report 📈 Stocks 🌍 United States ISIN US30040W1080

Eversource Energy Shares Slip 11% From Highs Amid Q2 Earnings Headwinds

Eversource Energy trails the broader market as Q2 charges and regulatory headwinds weigh on performance, leading analysts to maintain a cautious hold rating on the stock.

🕐 1 min read

3 assets impacted. Net bias: 1 Bullish, 1 Bearish, 1 Neutral. Strongest signal: ES ↓ 6/10 (62% confidence).

📊 Affected Assets (3)

ES
Bearish 🤖 62%
📆 Mid-term 🌍 US · Explicit

Eversource reported lower Q2 earnings with charges from the Aquarion Water sale and increased offshore wind liability, and faces reduced transmission profitability due to the FERC ROE decision.

ETR
Bullish 🤖 55%
📆 Mid-term 🌍 US · Explicit

Entergy is cited as a rival that has outperformed Eversource with higher YTD and 52-week gains.

DOWI
Neutral 🤖 60%
📅 Short-term 🌍 US · Explicit

The Dow Jones Industrial Average is used as a benchmark showing Eversource's underperformance over multiple periods.

🎯 Key Takeaways

  • Eversource Q2 earnings were hit by a $111.4 million charge from the Aquarion Water sale and a $164 million offshore wind liability.
  • The stock is underperforming the Dow Jones Industrial Average, with a 2.8% decline over the past three months.
  • Regulatory pressure from a FERC decision lowering transmission ROE to 9.57% continues to impact profitability.
  • Rival Entergy Corporation has significantly outperformed Eversource, posting a 16.7% gain over the past 52 weeks.

📝 Executive Summary

Eversource Energy shares face mid-term pressure after reporting a sharp Q2 earnings decline to $53.7 million. The utility provider is grappling with significant charges from the Aquarion Water sale, increased offshore wind liabilities, and a FERC-mandated reduction in transmission return on equity.

❓ FAQ

Why has Eversource Energy stock underperformed recently?

The stock has been pressured by a sharp drop in Q2 earnings, specific charges related to the Aquarion Water divestiture, rising offshore wind liabilities, and a regulatory reduction in transmission return on equity.